Should second doses be delayed? Should most adults receive half-doses? Scientists are pondering ways to get more shots into more arms.
Source: New York Times
As Rollout Falters, Scientists Debate New Vaccination Tactics
Published in AstraZeneca PLC, Clinical Trials, Coronavirus (2019-nCoV), Food and Drug Administration, Great Britain, Immune System, Marks, Peter, Pfizer Inc, Public-Private Sector Cooperation, United States, Vaccination and Immunization and Wachter, Robert M
More from AstraZeneca PLCMore posts in AstraZeneca PLC »
More from Clinical TrialsMore posts in Clinical Trials »
More from Coronavirus (2019-nCoV)More posts in Coronavirus (2019-nCoV) »
More from Food and Drug AdministrationMore posts in Food and Drug Administration »
More from Great BritainMore posts in Great Britain »
More from Immune SystemMore posts in Immune System »
More from Pfizer IncMore posts in Pfizer Inc »
More from Public-Private Sector CooperationMore posts in Public-Private Sector Cooperation »
More from United StatesMore posts in United States »
Be First to Comment